ClinicalTrials.Veeva

Menu

Effective Management of Calcific Aortic Stenosis in the Elderly (RAC)

F

French Cardiology Society

Status

Completed

Conditions

Calcific Aortic Stenosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Although aortic valve replacement is recommended for any symptomatic severe calcific aortic stenosis, the therapeutic decision may be difficult. because of patient age and comorbidities.

Transcatheter Aortic Valve Implantation (TAVI) has recently extended the therapeutic indications in patients at high risk of surgery. However, the proportion of different treatments is not known in a contemporary population that can be treated according to the different resources currently available.

The scientific goal of this observational research is to evaluate intra-hospital therapeutic decision in elderly patients referred because of symptomatic severe aortic stenosis.

The one-year survival will be analyzed according to the therapeutic decision and the characteristics of the patients.

Enrollment

1,101 patients

Sex

All

Ages

75+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalized due to symptomatic tight aortic stenosis (NYHA >= II, dyspnea, angina or syncope);
  • Having given his consent to participate in the study.

Exclusion criteria

  • Non-severe aortic stenosis;
  • Asymptomatic aortic stenosis;
  • Patient under the age of 75;
  • Patient refusing to participate in the study.

Trial design

1,101 participants in 1 patient group

Hospitalized patients due to a severe, symptomatic aortic sten
Description:
Patients who agreed to participate in the study, aged ≥75 years, with severe and symptomatic aortic stenosis, and hospitalized in one of the medical and surgical centers participating in the study

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems